Perspective Historical Financial Ratios
| CATX Stock | 3.71 0.29 7.25% |
Perspective Therapeutics is promptly reporting on over 91 different financial statement accounts. To analyze all of these accounts together requires a lot of time and effort. However, using these accounts to derive some meaningful and actionable indicators such as Dividend Yield of 0.0, PTB Ratio of 1.36 or Days Sales Outstanding of 314 will help investors to properly organize and evaluate Perspective Therapeutics financial condition quickly.
Perspective |
About Perspective Financial Ratios Analysis
Perspective TherapeuticsFinancial ratios are relationships based on a company's financial information. They can serve as useful tools to evaluate Perspective Therapeutics investment potential. Financial ratio analysis can also be defined as the process of presenting financial ratios, which are mathematical indicators calculated by comparing key financial information appearing on Perspective financial statements. Financial ratios are useful tools that help investors analyze and compare relationships between different pieces of financial information across Perspective Therapeutics history.
Perspective Therapeutics Financial Ratios Chart
Add Fundamental
Price To Sales Ratio
Price to Sales Ratio is figured by comparing Perspective Therapeutics stock price to its revenues. An advantage to using Price to Sales ratio is that it is based on Perspective Therapeutics sales, a figure that is much harder to manipulate than other Perspective Therapeutics multiples. Because sales tend to be more stable P/S ratio can be a good tool for screening cyclical companies fluctuating earnings patterns. A valuation ratio that compares a company's stock price to its revenues, calculated by dividing the company's market cap by its total sales or revenue over a 12-month period.Dividend Yield
Dividend Yield is Perspective Therapeutics dividend as a percentage of Perspective Therapeutics stock price. Perspective Therapeutics dividend yield is a measure of Perspective Therapeutics stock productivity, which can be interpreted as interest rate earned on an Perspective Therapeutics investment. A financial ratio that shows how much a company pays out in dividends each year relative to its stock price, calculated as annual dividends per share divided by price per share.Ptb Ratio
Price-to-Book ratio, a financial valuation metric used to compare a company's current market price to its book value. It provides insight into the value that market participants place on the company's equity relative to its net asset value.Operating Cash Flow Per Share
A measure of the cash generated from a company's normal business operations per share, indicating how much cash is generated from a company's business operations on a per-share basis.Most ratios from Perspective Therapeutics' fundamentals are interrelated and interconnected. However, analyzing fundamentals ratios one by one will only give a small insight into Perspective Therapeutics current financial condition. On the other hand, looking into the entire matrix of fundamentals ratios, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Perspective Therapeutics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate. For more information on how to buy Perspective Stock please use our How to Invest in Perspective Therapeutics guide.At this time, Perspective Therapeutics' Dividend Yield is fairly stable compared to the past year. Days Sales Outstanding is likely to rise to 314.03 in 2024, whereas Price To Sales Ratio is likely to drop 55.63 in 2024.
| 2021 | 2022 | 2023 | 2024 (projected) | Days Sales Outstanding | 54.37 | 70.03 | 299.08 | 314.03 | PTB Ratio | 7.16 | 6.42 | 1.43 | 1.36 |
Perspective Therapeutics fundamentals Correlations
Click cells to compare fundamentals
Perspective Therapeutics Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Perspective Therapeutics fundamentals Accounts
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Price To Sales Ratio | 38.83 | 82.43 | 40.64 | 49.41 | 75.03 | 55.63 | |
| Ptb Ratio | 65.68 | 12.29 | 7.16 | 6.42 | 1.43 | 1.36 | |
| Days Sales Outstanding | 77.07 | 73.09 | 54.37 | 70.03 | 299.08 | 314.03 | |
| Book Value Per Share | 0.11 | 0.0847 | 0.65 | 0.43 | 2.81 | 2.67 | |
| Free Cash Flow Yield | (0.02) | (0.0104) | (0.003883) | (0.0355) | (0.35) | (0.34) | |
| Operating Cash Flow Per Share | (0.0539) | (0.0273) | (0.0543) | (0.0857) | (1.38) | (1.45) | |
| Stock Based Compensation To Revenue | 0.0574 | 0.0511 | 0.0384 | 0.19 | 2.61 | 2.74 | |
| Capex To Depreciation | 1.86 | 2.56 | 1.07 | 0.88 | 1.13 | 1.08 | |
| Pb Ratio | 65.68 | 12.29 | 7.16 | 6.42 | 1.43 | 1.36 | |
| Ev To Sales | 38.69 | 76.16 | 35.51 | 46.45 | 70.37 | 49.21 | |
| Free Cash Flow Per Share | (0.0579) | (0.031) | (0.0562) | (0.0878) | (1.42) | (1.49) | |
| Roic | (0.49) | (0.0474) | (0.12) | (0.28) | (0.5) | (0.52) | |
| Inventory Turnover | 7.06 | 5.03 | 4.43 | 3.88 | 4.46 | 4.24 | |
| Net Income Per Share | (0.0484) | (0.0307) | (0.0504) | (0.1) | (1.74) | (1.82) | |
| Days Of Inventory On Hand | 51.67 | 72.53 | 82.46 | 94.02 | 84.62 | 88.85 | |
| Payables Turnover | 6.97 | 6.76 | 6.4 | 3.55 | 4.08 | 7.74 | |
| Capex To Revenue | 0.0282 | 0.0379 | 0.0246 | 0.0425 | 0.75 | 0.78 | |
| Cash Per Share | 0.0354 | 0.61 | 0.39 | 0.31 | 0.35 | 0.33 | |
| Pocfratio | (103.23) | (292.09) | (56.91) | (28.84) | (2.91) | (3.06) | |
| Payout Ratio | (0.001642) | (0.002268) | (0.003365) | (0.002823) | (0.002541) | (0.002668) | |
| Pfcf Ratio | (96.03) | (257.51) | (55.01) | (28.14) | (2.83) | (2.97) | |
| Days Payables Outstanding | 52.39 | 54.02 | 57.06 | 102.83 | 118.25 | 112.34 | |
| Income Quality | 0.85 | 0.98 | 1.06 | 0.84 | 0.83 | 0.48 | |
| Roe | (0.57) | (0.0473) | (0.12) | (0.27) | (0.62) | (0.65) | |
| Ev To Operating Cash Flow | (102.85) | (269.86) | (49.72) | (27.11) | (2.73) | (2.87) | |
| Pe Ratio | (114.98) | (259.93) | (61.34) | (23.93) | (2.31) | (2.43) | |
| Return On Tangible Assets | (0.38) | (0.0454) | (0.11) | (0.25) | (1.98) | (1.88) | |
| Ev To Free Cash Flow | (95.68) | (237.91) | (48.07) | (26.46) | (2.66) | (2.79) | |
| Earnings Yield | (0.008697) | (0.003847) | (0.0163) | (0.0418) | (0.43) | (0.41) | |
| Intangibles To Total Assets | 0.0159 | 0.001846 | 0.00166 | 0.00148 | 0.76 | 0.8 | |
| Net Debt To E B I T D A | 0.4 | 18.39 | 7.49 | 1.41 | 0.17 | 0.16 | |
| Current Ratio | 3.5 | 37.37 | 26.18 | 19.89 | 1.07 | 1.02 | |
| Tangible Book Value Per Share | 0.11 | 0.0826 | 0.65 | 0.43 | 0.0285 | 0.0271 |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for Perspective Stock Analysis
When running Perspective Therapeutics' price analysis, check to measure Perspective Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Perspective Therapeutics is operating at the current time. Most of Perspective Therapeutics' value examination focuses on studying past and present price action to predict the probability of Perspective Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Perspective Therapeutics' price. Additionally, you may evaluate how the addition of Perspective Therapeutics to your portfolios can decrease your overall portfolio volatility.